Okay, let's tackle this question about Tay-Sachs disease. The question is asking which enzyme is deficient in this condition. First, I need to recall what Tay-Sachs is. From what I remember, it's a lysosomal storage disease. Lysosomal storage diseases are caused by enzyme deficiencies that lead to the accumulation of substances in the lysosomes.

Tay-Sachs specifically is related to gangliosides, right? The name ganglioside comes to mind because the disease affects the nervous system. The enzyme involved here is hexosaminidase. There are different types of hexosaminidase, like A and B. I think Tay-Sachs is specifically due to a deficiency in hexosaminidase A. This enzyme is responsible for breaking down GM2 gangliosides. Without it, these gangliosides accumulate in neurons, leading to progressive neurological deterioration.

Now, let's consider the other options. If the options included other enzymes like hexosaminidase B, that's part of a different disease, maybe Sandhoff disease. Or maybe there's beta-glucuronidase, which is involved in another lysosomal storage disorder. Also, maybe there's alpha-galactosidase for Fabry disease. But the key here is the specific enzyme for Tay-Sachs.

For the clinical pearl, I should remember that Tay-Sachs is a classic autosomal recessive disorder, common in Ashkenazi Jewish populations. The cherry-red spot in the macula is a classic finding on eye exam. The enzyme deficiency leads to GM2 accumulation, so the correct answer is hexosaminidase A deficiency.

Wait, the options aren't provided, but the correct answer is supposed to be hexosaminidase A. So when explaining the wrong options, I need to mention other enzymes like hexosaminidase B (which is part of Sandhoff disease), beta-glucuronidase (for mucolipidosis), or maybe alpha-galactosidase (Fabry). Each of these has different pathologies. The correct answer is hexosaminidase A, so the explanation should clarify why the others are incorrect based on their respective diseases.

**Core Concept**
Tay-Sachs disease is an autosomal recessive **lysosomal storage disorder** caused by deficiency of **beta-hexosaminidase A**, leading to accumulation of **GM2 gangliosides** in neurons. This enzyme deficiency disrupts the catabolism of gangliosides, primarily affecting the central nervous system.

**Why the Correct Answer is Right**
**Hexosaminidase A** is a lysosomal enzyme that cleaves terminal N-acetyl-D-galactosamine residues from GM2 gangliosides. Its absence causes GM2 ganglioside accumulation in neurons, leading to progressive neurodegeneration, cherry-red macular spots, and early childhood mortality. The enzyme is encoded by the **HEXA gene**; mutations here are pathognomonic for Tay-Sachs.

**Why Each Wrong Option is Incorrect**
**Option A:** Hexosaminidase B deficiency causes Sandhoff disease, another GM2 gangliosidosis but with broader substrate involvement (e.g., ganglioside GM1).
**Option B:** Glucocerebrosidase deficiency leads to Gaucher disease, characterized by splen

✓ Correct Answer: A. Hexosaminidase-A